MUC16 showed significant co-expression with antigens (tumor-antigens & autoantigens) and acute phase reactants such as transglutaminases (TGM2), CEACAMs, C-Reactive Protein (CRP), and alkaline phosphatase (ALPP) (Supplementary File 1). This evidence concerns the gene MUC16 and neoplasm.